Browse

Snail and Cox-2 expressions are associated with WHO tumor grade and survival rate of patients with gliomas

DC Field Value Language
dc.contributor.authorMyung, Jaekyung-
dc.contributor.authorCho, Byung-Kyu-
dc.contributor.authorKim, Young-Soon-
dc.contributor.authorPark, Sung-Hye-
dc.date.accessioned2012-05-31T04:46:23Z-
dc.date.available2012-05-31T04:46:23Z-
dc.date.issued2010-06-
dc.identifier.citationNEUROPATHOLOGY; Vol.30 3; 224-231ko_KR
dc.identifier.issn0919-6544-
dc.identifier.urihttps://hdl.handle.net/10371/76666-
dc.description.abstractThe transcriptional factor Snail and enzyme cyclo-oxygenase-2 (Cox-2) are suggested to be important effectors of invasiveness and tumorigenesis in various tumors. Tumors of higher grade have the propensity for tumor cell migration and invasiveness. This study was performed in order to evaluate the association between Snail and Cox-2 expressions and their values as prognostic factors in various grades of glioma, Specimens of 56 patients with glioma were used in the study. Univariate analysis showed that WHO tumor grade, and expressions of Snail and Cox-2 were significant prognostic factors affecting overall and disease progression-free survival rates. In the multivariate analysis by Cox regression model, only WHO tumor grade was shown to be a significant independent prognostic factor of overall and progression-free survival rates. In conclusion, Snail and Cox-2 expressions were associated with WHO grade in gliomas and may be used as prognostic indicators.ko_KR
dc.language.isoenko_KR
dc.publisherWILEY-BLACKWELLko_KR
dc.subjectCox-2ko_KR
dc.subjectgliomako_KR
dc.subjectprognostic factorko_KR
dc.subjectSnailko_KR
dc.subjectimmunohistochemistryko_KR
dc.titleSnail and Cox-2 expressions are associated with WHO tumor grade and survival rate of patients with gliomasko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor명재경-
dc.contributor.AlternativeAuthor조병규-
dc.contributor.AlternativeAuthor김영순-
dc.contributor.AlternativeAuthor박성혜-
dc.identifier.doi10.1111/j.1440-1789.2009.01072.x-
dc.citation.journaltitleNEUROPATHOLOGY-
dc.description.citedreferenceOnguru O, 2008, NEUROPATHOLOGY, V28, P29, DOI 10.1111/j.1440-1789.2007.00828.x-
dc.description.citedreferenceD`Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019-
dc.description.citedreferenceYin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027-
dc.description.citedreferenceMartinez R, 2007, J NEURO-ONCOL, V83, P91, DOI 10.1007/s11060-006-9292-0-
dc.description.citedreferenceWong MLH, 2007, J CLIN NEUROSCI, V14, P301, DOI 10.1016/j.jocn.2006.11.005-
dc.description.citedreferenceWeingart J, 2007, J CLIN ONCOL, V25, P399, DOI 10.1200/JCO.2006.06.6290-
dc.description.citedreferenceDing JX, 2006, GYNECOL ONCOL, V103, P623, DOI 10.1016/j.ygyno.2006.04.023-
dc.description.citedreferenceOnguru O, 2006, CLIN NEUROPATHOL, V25, P216-
dc.description.citedreferenceDohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635-
dc.description.citedreferenceKyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021-
dc.description.citedreferencePhillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019-
dc.description.citedreferenceLayfield LJ, 2006, APPL IMMUNOHISTO M M, V14, P91-
dc.description.citedreferenceWick W, 2006, CURR PHARM DESIGN, V12, P341-
dc.description.citedreferenceEntz-Werle N, 2005, INT J CANCER, V117, P349, DOI 10.1002/ijc.21068-
dc.description.citedreferenceKoul D, 2005, MOL CANCER THER, V4, P1681, DOI 10.1158/1535-7163.MCT-05-0258-
dc.description.citedreferenceQuinn JA, 2005, J CLIN ONCOL, V23, P7178, DOI 10.1200/JCO.2005.06.502-
dc.description.citedreferenceElias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352-
dc.description.citedreferenceLippman SM, 2005, CLIN CANCER RES, V11, P6097, DOI 10.1158/1078-0432.CCR-05-1217-
dc.description.citedreferenceJorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465-
dc.description.citedreferenceKwok WK, 2005, CANCER RES, V65, P5153-
dc.description.citedreferenceMartin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010-
dc.description.citedreferenceKaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115-
dc.description.citedreferenceKESARI S, 2005, CURR NEUROL NEUROSCI, V5, P186-
dc.description.citedreferenceMorokoff AP, 2004, J CLIN NEUROSCI, V11, P807, DOI 10.1016/j.jocn.2004.03.004-
dc.description.citedreferenceKajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004-
dc.description.citedreferenceHara A, 2004, ACTA NEUROPATHOL, V108, P43, DOI 10.1007/s00401-004-0860-0-
dc.description.citedreferenceYang J, 2004, CELL, V117, P927-
dc.description.citedreferenceVega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104-
dc.description.citedreferenceOnguru O, 2004, ENDOCR PATHOL, V15, P17-
dc.description.citedreferencePeinado HC, 2004, INT J DEV BIOL, V48, P365-
dc.description.citedreferenceDannenberg AJ, 2003, CANCER CELL, V4, P431-
dc.description.citedreferenceSeki K, 2003, J BIOL CHEM, V278, P41862, DOI 10.1074/jbc.M308336200-
dc.description.citedreferenceLin CD, 2003, AM J CLIN ONCOL-CANC, V26, pS98-
dc.description.citedreferenceSugimachi K, 2003, CLIN CANCER RES, V9, P2657-
dc.description.citedreferenceGuaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200-
dc.description.citedreferenceFraga ME, 2002, BIOTECHNIQUES, V33, P632-
dc.description.citedreferenceZhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866-
dc.description.citedreferenceHajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083-
dc.description.citedreferenceThiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822-
dc.description.citedreferenceBlanco MJ, 2002, ONCOGENE, V21, P3241-
dc.description.citedreferenceNieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757-
dc.description.citedreferenceFRAGA MF, 2002, BIOTECHNIQUES, V33, P636-
dc.description.citedreferenceFRAGA MF, 2002, BIOTECHNIQUES, V33, P634-
dc.description.citedreferenceComijn J, 2001, MOL CELL, V7, P1267-
dc.description.citedreferenceShono T, 2001, CANCER RES, V61, P4375-
dc.description.citedreferenceArias AM, 2001, CELL, V105, P425-
dc.description.citedreferenceEsteller M, 2000, NEW ENGL J MED, V343, P1350-
dc.description.citedreferenceHemavathy K, 2000, GENE, V257, P1-
dc.description.citedreferenceJoki T, 2000, CANCER RES, V60, P4926-
dc.description.citedreferenceGrooteclaes ML, 2000, ONCOGENE, V19, P3823-
dc.description.citedreferenceCano A, 2000, NAT CELL BIOL, V2, P76-
dc.description.citedreferenceBatlle E, 2000, NAT CELL BIOL, V2, P84-
dc.description.citedreferenceDannenberg AJ, 1999, SEMIN ONCOL, V26, P499-
dc.description.citedreferenceChristofori G, 1999, TRENDS BIOCHEM SCI, V24, P73-
dc.description.citedreferenceJaeckle KA, 1998, J CLIN ONCOL, V16, P3310-
dc.description.citedreferenceKnott JCA, 1998, INT J CANCER, V75, P864-
dc.description.citedreferenceHuang M, 1998, CANCER RES, V58, P1208-
dc.description.citedreferenceSilber JR, 1998, CANCER RES, V58, P1068-
dc.description.citedreferenceAGOSTI RM, 1992, VIRCHOWS ARCH A, V420, P321-
dc.description.citedreferenceBEHRENS J, 1992, SEMIN CELL BIOL, V3, P169-
dc.description.citedreferenceBIGNER SH, 1990, CANCER RES, V50, P8017-
dc.description.tc2-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Pathology (병리학전공)Journal Papers (저널논문_병리학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse